Morehead City, NORTH%20CAROLINA1 Active Studies

Recurrent Pregnancy Loss Clinical Trials in Morehead City, NORTH%20CAROLINA

Find 1 actively recruiting recurrent pregnancy loss clinical trials in Morehead City, NORTH%20CAROLINA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
150
Enrolling

Recruiting Recurrent Pregnancy Loss Studies in Morehead City

About Recurrent Pregnancy Loss Clinical Trials in Morehead City

Recurrent pregnancy loss is defined as two or more failed pregnancies and affects about 1-2% of couples trying to conceive. Causes include chromosomal abnormalities, uterine anomalies, and immune factors. Treatment depends on the underlying cause and may include hormonal support, surgery, or immunotherapy.

There are currently 1 recurrent pregnancy loss clinical trials recruiting participants in Morehead City, NORTH%20CAROLINA. These studies are seeking a combined 150 participants. Research is being sponsored by Crinetics Pharmaceuticals Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Recurrent Pregnancy Loss Clinical Trials in Morehead City — FAQ

Are there recurrent pregnancy loss clinical trials in Morehead City?

Yes, there are 1 recurrent pregnancy loss clinical trials currently recruiting in Morehead City, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Morehead City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Morehead City research site will contact you about next steps.

Are clinical trials in Morehead City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Morehead City studies also compensate for your time and travel.

What recurrent pregnancy loss treatments are being tested?

The 1 active trials in Morehead City are testing new therapies including novel drugs, biologics, and treatment approaches for recurrent pregnancy loss.

Data updated March 2, 2026 from ClinicalTrials.gov